Title : The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss.

Pub. Date : 2014 Mar

PMID : 24316417






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Finally, we showed that ibrutinib administration ameliorated the bone loss that developed in a RANKL-induced osteoporosis mouse model. ibrutinib tumor necrosis factor (ligand) superfamily, member 11 Mus musculus